Stanford Med Students Offered Option to Study Their Own Genotype Data
By GenomeWeb,
GenomeWeb Daily News
| 06. 07. 2010
Stanford University School of Medicine today said that it will offer a new course that gives medical and graduate students an option to study their personal genotype data.
The university said that it believes it is the first medical school to offer students such a course. However, the University of Pennsylvania School of Medicine offered its fourth-year medical students a similar course in personalized medicine this past year.
In the Stanford course, students will learn how to analyze, evaluate, and interpret the genetic data, the limitations of existing technologies, and the legal and ethical issues surrounding personal genotyping.
The course will be an elective and will be offered during the school's summer quarter, which begins June 21.
The UPenn course also included a discussion of the ethical, legal, and social implications of personalized medicine, according to Professor Reed Pyeritz, who offered the course and is director of the school's Center for the Integration of Genetic Healthcare Technologies. Students in the UPenn course were offered an option to have their genome scanned by the Coriell Personalized Medicine Collaborative.
Recently, the University...
Related Articles
By Darren Incorvaia, Fierce Biotech | 07.16.2026
Jennifer Doudna, Ph.D., the Nobel Laureate best known for co-inventing the CRISPR system that has become the foundation for gene editing, is dipping her toes into a new, buzzy field: AI-powered protein design.
In a new paper, published today...
By Risa Cromer, The Conversation | 07.17.2026
By Emily Packard Dawson and Lainie Friedman Ross , The Hastings Center for Bioethics | 07.16.2026
Major news outlets recently reported – based on a bioRxiv preprint – that scientists had edited genes in human embryos with “startling precision.” The scientists’ decision to release this work ahead of peer review, coupled with the extensive media coverage...
Media coverage of recent developments in embryo gene editing might seem to suggest that gene-edited babies are close to becoming a reality. As tech billionaires eager to profit off of techno-eugenics invest in “designer baby” technologies, attempts to normalize heritable genome editing – which remains unsafe and raises significant ethical and societal concerns – are especially dangerous. It’s worth taking a closer look at these developments and what they mean, in a way that pushes back on narratives normalizing the...
